Featured Research

from universities, journals, and other organizations

Social deprivation a key factor in mortality in type 1 diabetes

Date:
September 24, 2013
Source:
Diabetologia
Summary:
Levels of social deprivation, as well as how well a patient controls their blood sugar, is an independent risk factor for mortality in people with type 1 diabetes.

Levels of social deprivation, as well as how well a patient controls their blood sugar, is an independent risk factor for mortality in people with type 1 diabetes. These are the findings of new research presented at this year's annual meeting of the European Association for the Study of Diabetes in Barcelona, Spain. The research is by the Diabetes Clinical Academic Group at King's Healthcare Partners, UK, and presented by Dr Stephen Thomas, Dept of Diabetes and Endocrinology, Guy's and St Thomas' Hospitals NHS Foundation Trust (GSTT), London.

Despite advances in care in recent decades, patients with type 1 diabetes continue to have increased mortality and morbidity. "In order to optimise specialist services with the aim of improving outcomes, this study set out to determine modifiable factors that influence mortality in type 1 diabetes," says Dr Thomas.

The researchers analysed blood sugar control (HbA1c levels), demographics and health resource utilisation data collected over a 10 year period for a cohort of 1038 patients with type 1 diabetes attending two inner city London specialist diabetes outpatient clinics. (GSTT and King's College hospital) All patients attending the service in 2002 with HbA1c data, a measure of blood glucose control, available for each year from 2002 to 2004 and with ongoing follow-up within the clinics until 2010 were included. Economic status was determined using the index of multiple deprivation (IMD) a weighted deprivation score derived from a national dataset based on postcode of residence.

The group had a mean age at baseline of 42 years and had had diabetes for a mean of 18 years . The average baseline HbA1c between 2002 and 2004 was 8.1%. In total, 37 deaths occurred by 2012 (3.6% cumulative mortality). Those who died were on average older with a higher mean baseline HbA1c (9.1%) Having a baseline HbA1c over 9.0% carried a cumulative 10-year morality that was significantly increased at 9%. Those who died were more likely to be socially deprived, with 61% of deceased patients having scores in the poorest 20% of the population range (mean IMD score 32 points deceased vs 24 points for patients still alive). Age, HbA1c and deprivation were all independent risk factors for death of patients with type 1 diabetes.

Dr Thomas concludes: "Glycaemic control and social deprivation are independent risk factors for mortality in type 1 diabetes and identify areas where we need to target interventions to improve health outcomes."

He adds: "This data analysis is ongoing and offers the possibility of much needed insights into where healthcare outcomes need to be addressed."


Story Source:

The above story is based on materials provided by Diabetologia. Note: Materials may be edited for content and length.


Cite This Page:

Diabetologia. "Social deprivation a key factor in mortality in type 1 diabetes." ScienceDaily. ScienceDaily, 24 September 2013. <www.sciencedaily.com/releases/2013/09/130924193621.htm>.
Diabetologia. (2013, September 24). Social deprivation a key factor in mortality in type 1 diabetes. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/09/130924193621.htm
Diabetologia. "Social deprivation a key factor in mortality in type 1 diabetes." ScienceDaily. www.sciencedaily.com/releases/2013/09/130924193621.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins